The board of directors of OrthoAccel Technologies Inc has named David Josza, an orthodontic and dental industry senior executive, as CEO. Josza’s position will go into effect August 1, 2017.
A privately owned medical technology start-up, OrthoAccel recently launched its third-generation vibratory orthodontic device AcceleDent Optima that the company says enables orthodontists to achieve more predictable outcomes.
“OrthoAccel is a market leader in accelerated orthodontic technology and I am delighted to lead the company’s next phase of growth and innovation,” said Josza in a release. “This is an exciting stage in OrthoAccel’s trajectory and, based on the feedback of orthodontists and patients who have experienced the new AcceleDent Optima, there is significant opportunity for growth ahead for this best-in-class treatment technology.”
Josza most recently served as corporate vice president and general manager for Zimmer Biomet Dental, a leading global manufacturer of musculoskeletal devices. He joined Zimmer in 2015 when the company acquired his previous firm, Biomet Inc, and Josza was tapped to lead the complex acquisition integration.
Prior to the acquisition, Josza had a 14-year career at Biomet 3i, a global implant and oral reconstructive supplier, most recently serving as vice president of the Americas.
In addition to his leadership roles at Zimmer and Biomet, Josza’s experience includes previous business development, strategic planning, and management responsibilities at Henry Schein Inc and Stryker Corporation.
“We are excited to welcome David and recognize that his in-depth experience in dental and medical industries, combined with his many successes as a strategist and business developer, provide an excellent leadership platform for his role at OrthoAccel Technologies,” Brian R. Smith, chairman of OrthoAccel’s board of directors and managing director of S3Ventures, said in a release.
